TEST:

NGS Targeted Hotspot Panel

"EntroGen, Inc. announces the immediate availability of its new NGS Targeted Hotspot Panel (THSP) designed to detect the most clinically relevant hotspot mutations in 16 genes across diverse tumor types. The panel is compatible with Illumina® MiniSeq, MiSeq and NexSeq 500. The company is obtaining a CE-IVD marking in the EU for the NGS Targeted Hotspot Panel. It is currently available worldwide for research use only."